VERAPAMIL AND PROPRANOLOL IN ESSENTIAL-HYPERTENSION

被引：55

作者：

HALPERIN, AK

GROSS, KM

ROGERS, JF

CUBEDDU, LX

机构：

[1] UNIV N CAROLINA, SCH MED,DEPT PHARMACOL,DIV CLIN PHARMACOL, 104 MACNIDER BLDG,ROOM 202H, CHAPEL HILL, NC 27514 USA

[2] UNIV N CAROLINA, SCH MED, DEPT MED, DIV GEN MED, CHAPEL HILL, NC 27514 USA

[3] WAKE AREA HLTH EDUC CTR, RALEIGH, NC USA

来源：

关键词：

D O I：

10.1038/clpt.1984.253

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：750 / 758

页数：9

共 22 条

[1] ANAVEKAR SN, 1982, J CARDIOVASC PHARM, V4, pS374
[2] BRAUNWALD E, 1982, NEW ENGL J MED, V307, P1618
[3] BUHLER FR, 1982, J CARDIOVASC PHARM, V4, pS350
[4] Candau L A, 1981, Arq Bras Cardiol, V37, P133
[5] CALCIUM, VASCULAR SMOOTH-MUSCLE, AND CALCIUM ENTRY BLOCKERS IN HYPERTENSION
COHN, JN
[J]. ANNALS OF INTERNAL MEDICINE, 1983, 98 (05) : 806 - 809
[6] DOYLE AE, HYPERTENSION S2, V5, P103
[7] FREIS ED, 1982, JAMA-J AM MED ASSOC, V248, P2004
[8] CLINICAL RELEVANCE OF VERAPAMIL PLASMA-LEVELS IN STABLE ANGINA-PECTORIS
FRISHMAN, W
KIRSTEN, E
KLEIN, M
PINE, M
JOHNSON, SM
HILLIS, LD
PACKER, M
KATES, R
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1982, 50 (05) : 1180 - 1184
[9] COMPARISON OF ORAL PROPRANOLOL AND VERAPAMIL FOR COMBINED SYSTEMIC HYPERTENSION AND ANGINA-PECTORIS - A PLACEBO-CONTROLLED DOUBLE-BLIND RANDOMIZED CROSSOVER TRIAL
FRISHMAN, WH
KLEIN, NA
KLEIN, P
STROM, JA
TAWIL, R
STRAIR, R
WONG, B
ROTH, S
LEJEMTEL, TH
POLLACK, S
SONNENBLICK, EH
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1982, 50 (05) : 1164 - 1172
[10] GLANTZ SA, 1981, PRIMER BIOSTATISTICS, P87